Chengxing Lu - Search Results

Year	Number of Results
2004	1
2007	1
2008	1
2009	1
2010	2
2012	2
2013	1
2014	1
2016	1
2017	1
2018	3
2019	1
2020	1
2021	2
2022	4
2023	3
2024	2

1

Tumor-Agnostic Approvals: Insights and Practical Considerations.

Lu CC, Beckman RA, Li XN, Zhang W, Jiang Q, Marchenko O, Sun Z, Tian H, Ye J, Yuan SS, Yung G; Master Protocol subteam of the Statistical Methods in Oncology Scientific Working Group, Biopharmaceutical Session, American Statistical Association. Lu CC, et al. Clin Cancer Res. 2024 Feb 1;30(3):480-488. doi: 10.1158/1078-0432.CCR-23-1340. Clin Cancer Res. 2024. PMID: 37792436

2

Statistical Considerations on the Use of RWD/RWE for Oncology Drug Approvals: Overview and Lessons Learned.

Ro SK, Zhang W, Jiang Q, Li XN, Liu R, Lu CC, Marchenko O, Sun L, Zhao J. Ro SK, et al. Among authors: lu cc. Ther Innov Regul Sci. 2023 Jul;57(4):899-910. doi: 10.1007/s43441-023-00528-y. Epub 2023 May 13. Ther Innov Regul Sci. 2023. PMID: 37179264 Free PMC article. Review.

3

Practical Considerations and Recommendations for Master Protocol Framework: Basket, Umbrella and Platform Trials.

Lu CC, Li XN, Broglio K, Bycott P, Jiang Q, Li X, McGlothlin A, Tian H, Ye J. Lu CC, et al. Ther Innov Regul Sci. 2021 Nov;55(6):1145-1154. doi: 10.1007/s43441-021-00315-7. Epub 2021 Jun 23. Ther Innov Regul Sci. 2021. PMID: 34160785 Free PMC article. Review.

4

FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA Expression.

Sternberg CN, Petrylak DP, Bellmunt J, Nishiyama H, Necchi A, Gurney H, Lee JL, van der Heijden MS, Rosenbaum E, Penel N, Pang ST, Li JR, García Del Muro X, Joly F, Pápai Z, Bao W, Ellinghaus P, Lu C, Sierecki M, Coppieters S, Nakajima K, Ishida TC, Quinn DI. Sternberg CN, et al. Among authors: lu c. J Clin Oncol. 2023 Jan 20;41(3):629-639. doi: 10.1200/JCO.21.02303. Epub 2022 Oct 14. J Clin Oncol. 2023. PMID: 36240478 Free PMC article. Clinical Trial.

5

Statistical and Operational Considerations for 2-Stage Adaptive Designs with Simultaneous Evaluation of Overall and Marker-Selected Populations in Oncology Confirmatory Trials.

Zhang W, Ro S, Jiang Q, Li X, Liu R, Lu C', Marchenko O, Zhao J, Xu Z. Zhang W, et al. Among authors: lu c. Ther Innov Regul Sci. 2022 Jul;56(4):552-560. doi: 10.1007/s43441-022-00407-y. Epub 2022 May 3. Ther Innov Regul Sci. 2022. PMID: 35503503 Review.

6

Current usage and challenges of master protocols-based on survey results by ASA BIOP oncology methodology working group master protocol sub-team.

Li X, Lu C, Broglio K, Bycott P, Chen J, Jiang Q, Lin J, Ye J, Yin J. Li X, et al. Among authors: lu c. Ann Transl Med. 2022 Sep;10(18):1036. doi: 10.21037/atm-21-6139. Ann Transl Med. 2022. PMID: 36267733 Free PMC article. Review.

7

Considerations for master protocols using external controls.

Chen J, Li XN, Lu CC, Yuan S, Yung G, Ye J, Tian H, Lin J. Chen J, et al. Among authors: lu cc. J Biopharm Stat. 2024 Feb 16:1-23. doi: 10.1080/10543406.2024.2311248. Online ahead of print. J Biopharm Stat. 2024. PMID: 38363805

8

Accuracy and Safety of Novel Designs for Phase I Drug-Combination Oncology Trials.

Liu R, Yuan Y, Sen S, Yang X, Jiang Q, Li XN, Lu CC, Göneng M, Tian H, Zhou H, Lin R, Marchenko O. Liu R, et al. Among authors: lu cc. Stat Biopharm Res. 2022;14(3):270-282. doi: 10.1080/19466315.2022.2081602. Epub 2022 Aug 2. Stat Biopharm Res. 2022. PMID: 37275462 Free PMC article.

9

Borrowing Concurrent Information from Non-Concurrent Control to Enhance Statistical Efficiency in Platform Trials.

Liu J, Lu C, Jiang Z, Alemayehu D, Nie L, Chu H. Liu J, et al. Among authors: lu c. Curr Oncol. 2023 Mar 31;30(4):3964-3973. doi: 10.3390/curroncol30040300. Curr Oncol. 2023. PMID: 37185413 Free PMC article.

10

Effect of Baseline Subretinal Fluid on Treatment Outcomes in VIVID-DME and VISTA-DME Studies.

Korobelnik JF, Lu C, Katz TA, Dhoot DS, Loewenstein A, Arnold J, Staurenghi G. Korobelnik JF, et al. Among authors: lu c. Ophthalmol Retina. 2019 Aug;3(8):663-669. doi: 10.1016/j.oret.2019.03.015. Epub 2019 Mar 27. Ophthalmol Retina. 2019. PMID: 31103642 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

26 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year